Purchase Order HHSN269201200189P

This federal contract award, with ID AG32SDP150531, was issued by the Plains Area federal agency to Macrogen Clinical Laboratory, Inc. (Macrogen USA) on August 18, 2015. The $24,380.00 firm fixed-price purchase order is for "OTHER FUNCTIONS 2ND BAC SEQ (AS ITEMIZED ON QUOTATION #QN150810-U03)" services, with an ultimate completion date of September 30, 2016. The contract has no set-aside designation. Macrogen Clinical Laboratory, Inc. is the prime contractor, and there is no...

This federal contract award with ID HHSN272201600148P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services. The contract, valued at $9,420.00, was awarded to Macrogen Clinical Laboratory, Inc. (doing business as Macrogen USA) on December 2, 2015 for the provision of MACROGEN CLINICAL LABORATORY (AMBIS # 1767851) FOR BIO MATERIAL services. The contract has a firm fixed price and a completion...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a subsidiary of Macrogen, Inc. The $5,160.00 firm fixed-price purchase order is for MACROGEN (AMBIS #1555659) and has a period of performance ending on May 18, 2012. There was no set-aside designation for this award. Psomagen Inc. is a provider of genomic sequencing and bioinformatics services. Through this contract, the company likely delivered a range of advanced...

This is a firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Chenkwang Science, a for-profit organization based in South Korea. The $22,774.50 contract is for the delivery of Biomerieux reagents to support biological defense analytical capabilities at U.S. military medical treatment facilities in South Korea, such as Brian Allgood Army Community Hospital and the United States Naval Hospital in Okinawa, Japan. The order has an ultimate completion date of September 30,...

Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a firm fixed price delivery order for $15,048.75 from the Department of the Army Medical Command. This delivery order was awarded on February 24, 2021 with a completion date of February 20, 2024 and is for the provision of 500 ml DRI ECSTASY PLUS MDMA/MDA reagent kits to the Trippler Army Medical Center in Hawaii. Microgenics will perform this order from its location in Fremont, California...

Seqgen, Inc., an Asian-Pacific American minority-owned business based in Torrance, California, was awarded a firm fixed-price purchase order valued at $2,900 by the Plains Area office of a civilian federal agency for one-year maintenance services on an ABI 3730 genetic analyzer. The contract, awarded on September 9, 2019, with an ultimate completion date of September 14, 2020, was issued without a set-aside designation and will be performed in Manhattan, Kansas. This maintenance agreement, based...

This federal contract award reflects a Firm Fixed Price purchase order issued on June 19, 2019, to Seqgen, Inc., an Asian-Pacific American minority-owned business based in Torrance, California, for troubleshooting services on an ABI 3730 genetic analyzer. The contract, valued at $4,000 with completion targeted for July 26, 2019, was funded by a civilian agency under the Pacific West Area and performed at the contractor's Torrance facility. No set-aside designation was utilized for this...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Macrogen Clinical Laboratory, Inc. (doing business as Macrogen USA) for transcriptome sequencing services of up to 4GB in size. The contract has a ceiling value of $4,710.00 and an ultimate completion date of September 30, 2015. The contract was awarded on May 15, 2015 and does not have a set-aside...

This delivery order against the DRI ECSTASY task order was awarded by the Defense Health Agency to Microgenics Corporation on December 23, 2022, for $12,039. The order has a completion date of January 19, 2023 and is for clinical diagnostic services to be performed at Fort Meade, Maryland. Microgenics Corporation is a division of Thermo Electron Corporation, which will perform as the prime contractor. No set aside designation was used for this firm fixed price order. The Defense Health Agency...

Genbody Inc. was awarded a definitive contract valued at $10.3 million by the National Institutes of Health's National Heart, Lung and Blood Institute to support the Rapid Acceleration of Diagnostics Technology Program, Project 6658. Under this firm fixed-price contract, Genbody will deliver diagnostic technologies to HHS/NIH over a two-year period of performance based in South Korea. The Rapid Acceleration program aims to expedite the development and review of critical medical diagnostics,...